ArticleApplied health economics and health policy2024

Cost Effectiveness of Molecular Diagnostic Testing Algorithms for the Treatment Selection of Frontline Ibrutinib for Patients with Chronic Lymphocytic Leukemia in Australia.

Martin Vu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.